Academic Clinical Fellow

Aetiology and Mechanisms of Diabetes and Related Metabolic Disorders of Later Life

Current work and interests

Dr Carina Tyrrell is a British-Swiss public health medical doctor and an NIHR research fellow at Cambridge University.

With government agencies and the Cambridge Judge Business School, Carina is working in operations and technology management, and in improving healthcare delivery. She has been identifying COVID-19 vaccine and therapeutic trials, publishing work with Oxford University.

She is a public health lead for the Fenland COVID-19 study at the MRC Epidemiology Unit. She is investigating the use of Huma software to identify digital bio-markers for pre-symptomatic COVID-19 infection and a home blood taking device from Drawbridge Health for antibody detection.

Background and experience

Carina practised medicine at Oxford University and research at the Global Outbreak Alert and Response Network (GOARN) at the World Health Organization, where she authored international policy documents on data sharing, research, and innovation, and published work on emerging respiratory viruses.

At the Wellcome Sanger Institute and Cambridge University Department of Pathology, she undertook research identifying therapeutic targets. She worked on behaviour change and prevention strategy for tackling non-communicable diseases at Cambridge Public Health.

Carina studied at Cambridge University where she graduated with a first class undergraduate degree in Natural Sciences (MA), a Bachelor of Medicine and Bachelor of Surgery (MB BChir), and a Master of Public Health (MPH) with distinction.

Professional membership and roles

• Council Member at Epidemiology & Public Health, Royal Society of Medicine
• Founder at Accelerate, Cambridge Judge Business School
• Venture Advisor, MBX Capital
• Former Miss United Kingdom at Miss World

Selected publications

• Tyrrell CSB et al. Influenza and emerging respiratory viruses. Medicine (2017) Volume 45 Issue 12 p. 55-61, ISSN 1357-3039
• Maguire BJ et al. Baseline results of a living systematic review for COVID-19 clinical trial registrations. Wellcome Open Research (2020) 5:116
• Makris GC et al. Closure Devices for Iatrogenic Thoraco-Cervical Vascular Injuries. Cardiovasc Intervent Radiol (2017) Volume 40 Issue 3 p. 381-387, PMID 27896414